Why does atorvastatin inhibit renal crystal retention?

Urological Research

Volumn 39, Issue 5, 2011, Pages 379-383

  Tsujihata, Masao ^a   Yoshioka, Iwao ^a   Tsujimura, Akira ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atorvastatin; Calcium oxalate urolithiasis; Catalase; NADPH oxidase; Rat; SOD; TGF

Indexed keywords

ATORVASTATIN; CATALASE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CALCIUM OXALATE STONE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME SUBUNIT; HYPEROXALURIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CALCIUM OXALATE; CATALASE; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; HEPTANOIC ACIDS; KIDNEY; KIDNEY CALCULI; MALE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; PYRROLES; RAC1 GTP-BINDING PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

EID: 80755189049     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-011-0370-1     Document Type: Article

References (23)

1. R Siener S Glatz C Nicolay, et al. 2003 Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium stone patients Eur Urol 44 467 474 14499683 10.1016/S0302-2838(03)00317-8 (Pubitemid 37185674)
2. SR Khan 2005 Hyperoxaluria-induced oxaidative stress and antioxidants for renal protection Urol Res 33 349 357 16292585 10.1007/s00240-005-0492-4 1:CAS:528:DC%2BD2MXht1Oqsb7P (Pubitemid 41752056)
3. M Takemoto JK Liao 2001 Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arterioscler Thromb Vasc Biol 21 1712 1719 11701455 10.1161/hq1101.098486 1:CAS:528:DC%2BD3MXosVKntLw%3D (Pubitemid 34219772)
4. N Glorioso C Troffa F Filigheddu, et al. 1999 Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia Hypertension 34 1281 1286 10601131 1:CAS:528:DC%2BD3cXivFCkuw%3D%3D (Pubitemid 30002395)
5. S Wassmann U Laufts K Muller, et al. 2002 Cellular antioxidant effects of atorvastatin in vitro and in vivo Arterioscler Thromb Vasc Biol 22 300 305 11834532 10.1161/hq0202.104081 1:CAS:528:DC%2BD38Xhtlyjsbg%3D (Pubitemid 34127043)
6. SI Kim DC Han HB Lee 2000 Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells J Am Soc Nephrol 11 80 87 10616843 1:CAS:528:DC%2BD3cXks1OgsQ%3D%3D (Pubitemid 30020429)
7. JE Toblli L Ferder I Stella, et al. 2002 Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria J Urol 168 1550 1555 12352456 10.1016/S0022-5347(05)64519-3 1:CAS:528:DC%2BD38Xot1Sqtrs%3D (Pubitemid 35034188)
8. M Tsujihata C Momohara I Yoshioka, et al. 2008 Atorvastatin inhibits renal crystal retention in a rat stone forming model J Urol 180 2212 2217 18804815 10.1016/j.juro.2008.07.024 1:CAS:528:DC%2BD1cXhtlWqs73J
9. C Nebat M Moutet P Huet, et al. 1993 Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol Anal Biochem 214 442 451 10.1006/abio.1993.1521 (Pubitemid 23336403)
10. H Shevalye R Stavniichuk W Xu, et al. 2010 Poly (ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model Biochem Pharmacol 79 1007 1014 19945439 10.1016/j.bcp.2009.11.018 1:CAS:528:DC%2BC3cXhtlais7w%3D
11. CR Wheeler JA Salzman NM Elsayed 1990 Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity Anal Biochem 184 193 199 2327564 10.1016/0003-2697(90)90668-Y 1:CAS:528:DyaK3cXhtlCru70%3D (Pubitemid 20055611)
12. BM Babior 1999 NADPH oxidase: an update Blood 93 1464 1476 10029572 1:CAS:528:DyaK1MXhsFertbg%3D (Pubitemid 29102471)
13. KK Griendling D Sorescu M Ushio-Fukai 2000 NAD(P)H oxidase: role in cardiovascular biology and disease Circ Res 86 494 501 10720409 1:CAS:528:DC%2BD3cXitFWhu7g%3D (Pubitemid 30165039)
14. YA Suh RS Arnold B Lassegue, et al. 1999 Cell transformation by the superoxidegenerating oxidase mox1 Nature 401 79 82 10485709 10.1038/43459 1:CAS:528:DyaK1MXlvVGmsbg%3D (Pubitemid 29418446)
15. T Chabrashvili C Kitiyakara J Blau, et al. 2003 Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression Am J Physiol Renal Integr Comp Physiol 285 R117 1:CAS:528:DC%2BD3sXlsFGhsrY%3D
16. Y Mizuguchi A Miyajima T Kosaka, et al. 2004 Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction J Urol 172 2456 2459 15538290 10.1097/01.ju.0000138473.38447.f0 1:CAS:528:DC%2BD2cXpsF2nsrg%3D (Pubitemid 39507552)
17. Yoshioka I, Tsujihata M, Akane W et al (2011) Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology. doi: 10.1016/j.urology.2010.11.019
18. TE Andreoli 2000 Free radicals and oxidative stress Am J Med 108 650 651 10856413 10.1016/S0002-9343(00)00418-6 1:STN:280:DC%2BD3czhsFKrsw%3D%3D (Pubitemid 30336604)
19. S Ebisuno Y Kohjimoto M Tamura, et al. 1995 Adhesion of calcium oxalate crystal to Madin-Darby canine kidney cells and some effects of glycosaminoglycans on cell injuries Eur Urol 28 68 73 8521899 1:STN:280:DyaK287isV2nsQ%3D%3D
20. JE Toblli L Ferder I Stella, et al. 2001 Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria J Urol 166 275 280 11435885 10.1016/S0022-5347(05)66144-7 1:CAS:528:DC%2BD3MXkvFems7c%3D (Pubitemid 32565411)
21. B Antus MS Exton L Rosivall 2001 AngiotensinII: a regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14 25 30 12622886 1:CAS:528:DC%2BD3MXjtFWgtr8%3D (Pubitemid 32268172)
22. T Umekawa Y Hatanaka T Kurita, et al. 2004 Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in the rat kidneys J Am Soc Nephrol 15 635 644 14978165 10.1097/01.ASN.0000113321.49771.2D 1:CAS:528:DC%2BD2cXhtlShtbY%3D (Pubitemid 38294793)
23. T Umekawa H Tsuji H Uemura, et al. 2009 Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals Br J Urol 104 115 120 1:CAS:528:DC%2BD1MXptVaqs7w%3D